HEXO Corporation (HEXO) Gets a Buy Rating from AltaCorp Captial

By Jason Carr

On June 14, an analyst has provided a rating update for HEXO Corporation (HEXOResearch Report). Analyst David Kideckel from AltaCorp Captial remains bullish on the stock and has a C$10.40 price target.

According to TipRanks.com, Kideckel is ranked #3814 out of 5201 analysts.

HEXO Corporation has an analyst consensus of Moderate Buy, with a price target consensus of C$10.70, implying a 44.2% upside from current levels. In a report issued on June 14, GMP FirstEnergy also reiterated a Buy rating on the stock with a C$9.50 price target.


HEXO Corporation’s market cap is currently C$1.57B and has a P/E ratio of 0. The company has a Price to Book ratio of 3.63.

HEXO Corp. engages in the manufacture, production, and distribution of medicinal marijuana. It offers products through the Time of Day, H2, Decarb, and Exlixir No. 1 brands. The company was founded by Sébastien St. Louis and Adam Miron on August 13, 2013 and is headquartered in Gatineau, Canada.

The company’s shares closed on Wednesday at C$7.41.